2nd Quarter - Report
VENN STRATEGIES for PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION
Firm
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAKARA MARIAH EASON New | — |
| ERIK ROBERT OLSON | — |
| JOHN RICHTER | — |
| TAHARVIS MALIK ROSS | — |
| MICHAEL SPIRA | — |
Budget/Appropriations BUD
Educating offices about paper labeling in FDA appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAKARA MARIAH EASON New | — |
| ERIK ROBERT OLSON | — |
| JOHN RICHTER | — |
| TAHARVIS MALIK ROSS | — |
| MICHAEL SPIRA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.